Sojo-Dorado J., López-Hernández I., Hernández-Torres A., Retamar-Gentil P., Merino De Lucas E., Escolà-Verge L., Bereciartua E., García-Vázquez E., Pintado V., Boix-Palop L., Natera-Kindelán C., Sorlí L., Borrell N., Amador-Prous C., Shaw E., Jover-Saenz A., Molina J., Martínez-Álvarez R.M., Dueñas C.J., Calvo-Montes J., Lecuona M., Pomar V., Borreguero I., Palomo-Jimenez V., Docobo-Perez F., Pascual Á., Rodríguez-Baño J.. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(7)DOI:10.1093/jac/dkad147. PMID:37260299. IF:3.900(Q1/3D).

de Mendoza C., Carrizo P., Sauleda S., Richart A., Rando A., Miró E., Benito R., Ayerdi O., Encinas B., Aguilera A., Reina G., Rojo S., González R., Fernández-Ruiz M., Liendo P., Montiel N., Roc L., Treviño A., Pozuelo M.J., Soriano V.. The slowdown of new infections by human retroviruses has reached a plateau in Spain. JOURNAL OF MEDICAL VIROLOGY. 2023; 95(5)DOI:10.1002/jmv.28779. PMID:37212269. IF:6.800(Q1/1D).

Pérez-Recio S., Grijota-Camino M.D., Anibarro L., Rabuñal-Rey R., Sabria J., Gijón-Vidaurreta P., Pomar V., García-Gasalla M., Domínguez-Castellano Á., Trigo M., Santos M.J., Cebollero A., Rodríguez S., Moga E., Penas-Truque A., Martos C., Ruiz-Serrano M.J., Garcia-De-Cara E.I., Alcaide F., Santin M.. Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study. PLoS One. 2023; 18(8)DOI:10.1371/journal.pone.0285917. PMID:37647315. IF:2.900(Q1/3D).

Batlle M., Badia J.M., Hernández S., Grau S., Padulles A., Boix-Palop L., Giménez-Pérez M., Ferrer R., Calbo E., Limón E., Pujol M., Horcajada J.P., Smithson A., Ros N.B., Gomila-Grange A., Pomar V., Toboso S.H., Murgadella-Sancho A., Perez-Hita A.O., Temple M.D., Molpeceres S.V., Pardo D.R., Río A.D., Luque M.F.S., Blanco N.V., Acedo S.O., Guitart S.S., Nicolas E.M., Noblia-Gigena L.B., Pérez O.D.R., Rodriguez M.P.G., Barcons I.A., Serra N.J., Calva L.C., Lérida A., Torras S.G., Martínez L.H., Miñambres C., Matellane J.M., Jofre C.S., Estada S.B., Carrascosa M.C., Mota S.T., Barrena D.S.. Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; 62(5)DOI:10.1016/j.ijantimicag.2023.106943. PMID:37541529. IF:4.900(Q1/2D).

Benito N., Martínez-Pastor J.C., Lora-Tamayo J., Ariza J., Baeza J., Belzunegui-Otano J., Cobo J., del-Toro M.-D., Fontecha C.G., Font-Vizcarra L., Horcajada J.P., Morata L., Murillo O., Nolla J.M., Núñez-Cuadros E., Pigrau C., Portillo M.E., Rodríguez-Pardo D., Sobrino-Díaz B., Saavedra-Lozano J.. Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2023; DOI:10.1016/j.eimc.2023.07.003. PMID:. IF:(Q/D).

Sainz L., Riera P., Moya P., Bernal S., Casademont J., Díaz-Torné C., Millán A.M., Park H.S., Lasa A., Corominas H.. Clinical Value of IL6R Gene Variants as Predictive Biomarkers for Toxicity to Tocilizumab in Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 2023; 13(1)DOI:10.3390/jpm13010061. PMID:36675722. IF:3.000(Q1/2D).

Colalillo A., Hoffmann-Vold A.-M., Pellicano C., Romaniello A., Gabrielli A., Hachulla E., Smith V., Simeón-Aznar C.-P., Castellví I., Airò P., Truchetet M.-E., Siegert E., Distler O., Rosato E.. The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohort. AUTOIMMUNITY REVIEWS. 2023; 22(4)DOI:10.1016/j.autrev.2023.103290. PMID:36746368. IF:9.200(Q1/1D).

Queiro R., Seoane-Mato D., Laiz A., Galindez Agirregoikoa E., Montilla C., Park H.S., Tasende J.A.P., Baute J.J.B., Joven Ibáñez B., Toniolo E., Ramírez J., Montero N., Pruenza García-Hinojosa C., Serrano García A.. Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning. Journal of Clinical Medicine. 2023; 12(3)DOI:10.3390/jcm12030931. PMID:36769579. IF:3.000(Q1/2D).